Kahira Pharmaceuticals (CPCI)

• Stock
• Company Profile
• News
• Announcements
• Fair Values
• Corporate Actions
• Earning Announcements
• News Reports
• Insider Trades
• Volume Statistics
• Financial Ratios
• IPOs
• Financial Statements
• Support and resistance
• More

{{ 'components.chart.period.' + period | translate }}

{{ 'components.chart.type.' + type | translate }}

This mark means that there are news on this date.

Stock

Par Value 10.00 Egyptian Pound

Market Cap 1,043,464,781.25 Egyptian Pound

Book Value (BVPS) 52.68 Egyptian Pound Based on: Third Quarter 2024

P/B Ratio 0.85 Last update: 2019-06-02

EPS 52.25 Egyptian Pound Based on: Third Quarter 2024

P/E Ratio 3.73 Last update: 2019-06-02

Trading Currency Egyptian Pound

Company Statistics

News

Kahira Pharmaceuticals' net profits up 22.5% in H1-21/22 Financial Results

Kahira Pharmaceuticals sees EGP 9m block trading deal Companies Investments

Adel Taha Abdel Wahab named Chairman of Kahira Pharmaceuticals Board of Directors

Kahira Pharmaceuticals posts 12% higher profit in nine months Financial Results

Kahira Pharmaceuticals targets EGP 145m profit in FY21/22 Financial Results

Pharma stocks lead EGX ahead of potential acquisitions Trading Activities

Market Announcements